A randomized trial comparing amitriptyline versus topiramate for the prophylaxis of chronic daily headache in pediatric patients

International Journal of Neuroscience

Volumn 123, Issue 8, 2013, Pages 553-556

  Sezer, Taner ^a   Kandemir, Hasan ^b   Alehan, Fusun ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Amitriptyline; Children; Chronic daily headache; Topiramate

Indexed keywords

AMITRIPTYLINE; TOPIRAMATE;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CHRONIC DAILY HEADACHE; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEX RATIO; TREATMENT RESPONSE; WEIGHT CHANGE;

ADOLESCENT; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HEADACHE DISORDERS; HUMANS; MALE;

EID: 84880468334     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.776048     Document Type: Article

References (20)

1. Silberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-Daily headaches: Proposed revisions to the IHS criteria. Headache 1994;34:1-7 (Pubitemid 24038967)
2. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in adolescents: Prevalence, impact, and medication overuse. Neurology 2006;66:193-97
3. Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol 2004;31:122-25 (Pubitemid 39070190)
4. Chakravarty A. Chronic daily headache in children and adolescents: A clinic based study from India. Cephalalgia 2005;25:795-800 (Pubitemid 41368674)
5. Hershey AD, Powers SW, Bentti AL, et al. Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurologist 2001;56:1032-37 (Pubitemid 32336309)
6. Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents: An 8 year follow-up study. Neurology 2009;73:416-22
7. Magnusson JE, Becker WJ, Riess CM. Effectiveness of a multidisciplinary treatment program for chronic daily headache. Can J Neurol Sci 2004;31:72-9 (Pubitemid 38325762)
8. Magalhaes E, Menezes C, Cardeal M, et al. Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. Clin Neurol Neurosurg 2010;112:463-66
9. Silvestrini M, Bartolini M, Coccia M, et al. Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23:820-24 (Pubitemid 37255424)
10. Couch J. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 2011;51:33-51
11. Krymchantowski AV, SilvaMT, Barbosa JS, et al. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: A double-blind study. Headache 2002;42:510-14 (Pubitemid 37011823)
12. Borzy JC, Koch TK, Schimschock Jr. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol 2005;33:314-16 (Pubitemid 41501549)
13. Hershey AD, Powers SW, Bentti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539-49 (Pubitemid 30497412)
14. Headache Classification Committee. The international classification of headache disorders, cranial neuralgia and facial pain, 2nd edition. Cephalalgia 2004;24:1-160
15. Pfaffenrath V, Diener HC, Isler H, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tensiontype headache: A multicentre controlled study. Cephalalgia 1994;14:149-55 (Pubitemid 24146150)
16. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-Type headache. J Neurol Neurosurg Psychiat 1996;61: 285-90 (Pubitemid 26293724)
17. Winner P, Pearlman EM, Linder SL, et al. Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial. Headache 2005;45: 1304-12 (Pubitemid 350004943)
18. Lewis D, Winner P, Saper J, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123:924-34
19. Dodick DW, Freitag F, Banks J, et al. Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-Dummy, parallelgroup noninferiority trial in adult migraineurs. Clin Ther 2009;31:542-59
20. Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: A systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr 2013;28:1-7